UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 21, 2019
Accession Number:
Submission Type:
CIK: 0000715446
Company Name: Anixa Biosciences Inc
File Number: 333-232067